| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8446460 | European Journal of Cancer | 2012 | 7 Pages |
Abstract
In this study of RO4929097 in patients with refractory metastatic colorectal cancer, no radiographic responses were seen and time to progression was short, which suggests that RO4929097 at the study dose and schedule has minimal single agent activity in this malignancy.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Jonathan R. Strosberg, Timothy Yeatman, Jill Weber, Domenico Coppola, Michael J. Schell, Gang Han, Khaldoun Almhanna, Richard Kim, Tiffany Valone, Helen Jump, Dan Sullivan,